Literature DB >> 24635475

Microparticle profile and procoagulant activity of fresh-frozen plasma is affected by whole blood leukoreduction rather than 24-hour room temperature hold.

Kasey Sze-Kei Chan1, Rosemary L Sparrow.   

Abstract

BACKGROUND: Microparticles (MPs) are small phospholipid-containing vesicles that have procoagulant properties. MPs are thought to contribute to the hemostatic potential of plasma. This study investigated the effects of whole blood (WB) hold time and leukoreduction (LR) on the MP profile and hemostatic potential of fresh-frozen plasma (FFP). STUDY DESIGN AND METHODS: WB units (n=12) from healthy donors were divided into two pairs and each pair was held at 20 to 24°C for 6 or 24 hours. At the designated hold time, 1 unit from the pair was LR while the other unit was not LR. FFP was prepared by standard procedures, aliquoted, and frozen. The MP content was determined by flow cytometry using an absolute count assay and specific labels for red blood cells (CD235a), platelets (CD41), and phosphatidylserine (PS). The hemostatic potential was determined by thrombelastography (TEG) and coagulation factor assays.
RESULTS: Compared to non-LR-FFP, LR-FFP had significantly lower numbers of MPs, particularly CD41+ MPs and PS-positive MPs (p<0.03). LR-FFP, compared to non-LR-FFP, had a slower clot formation time (p=0.002); lower clot strength (p<0.001); and lower Factor (F)VIII, FXII, and fibrinogen levels (p<0.01). With longer WB hold time, the TEG profile was unchanged, although FVIII levels were decreased as expected (p<0.01). On average FFP units met quality requirements.
CONCLUSION: LR of WB resulted in lower hemostatic potential of FFP in conjunction with depletion of MPs and coagulation factors. Longer WB hold time did not significantly affect the hemostatic potential of FFP as measured by TEG. Acceptable hemostatic quality was maintained for all FFP processing conditions studied.
© 2014 Australian Red Cross Blood Service. Transfusion © 2014 AABB.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24635475      PMCID: PMC4164532          DOI: 10.1111/trf.12602

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  40 in total

1.  Making contact with microparticles.

Authors:  S Shapiro; M Laffan
Journal:  J Thromb Haemost       Date:  2012-07       Impact factor: 5.824

Review 2.  Ectosomes as immunomodulators.

Authors:  Salima Sadallah; Ceylan Eken; Jürg A Schifferli
Journal:  Semin Immunopathol       Date:  2010-12-07       Impact factor: 9.623

Review 3.  Microparticles and acute lung injury.

Authors:  Mark McVey; Arata Tabuchi; Wolfgang M Kuebler
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-06-22       Impact factor: 5.464

4.  Platelet- and erythrocyte-derived microparticles trigger thrombin generation via factor XIIa.

Authors:  P E J Van Der Meijden; M Van Schilfgaarde; R Van Oerle; T Renné; H ten Cate; H M H Spronk
Journal:  J Thromb Haemost       Date:  2012-07       Impact factor: 5.824

Review 5.  Use of point-of-care testing for plasma therapy.

Authors:  Lawrence Tim Goodnough; Charles C Hill
Journal:  Transfusion       Date:  2012-05       Impact factor: 3.157

Review 6.  Plasma components: properties, differences, and uses.

Authors:  Richard John Benjamin; Lisa Swinton McLaughlin
Journal:  Transfusion       Date:  2012-05       Impact factor: 3.157

7.  The influence of platelets, plasma and red blood cells on functional haemostatic assays.

Authors:  Louise Bochsen; Pär I Johansson; Annemarie T Kristensen; Gedske Daugaard; Sisse R Ostrowski
Journal:  Blood Coagul Fibrinolysis       Date:  2011-04       Impact factor: 1.276

8.  Microparticle content of plasma for transfusion is influenced by the whole blood hold conditions: pre-analytical considerations for proteomic investigations.

Authors:  Rosemary L Sparrow; Kasey Sze-Kei Chan
Journal:  J Proteomics       Date:  2012-07-16       Impact factor: 4.044

Review 9.  Tissue factor-bearing microparticles and thrombus formation.

Authors:  Jeffrey I Zwicker; Cameron C Trenor; Barbara C Furie; Bruce Furie
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-01-20       Impact factor: 8.311

Review 10.  Plasma transfusion for patients with severe hemorrhage: what is the evidence?

Authors:  Jeannie L Callum; Sandro Rizoli
Journal:  Transfusion       Date:  2012-05       Impact factor: 3.157

View more
  7 in total

1.  Platelet-, leucocyte- and red cell-derived microparticles in stored whole blood, with and without leucofiltration, with and without ionising radiation.

Authors:  Shunnichi Saito; Kenneth E Nollet; Alain M Ngoma; Takako Ono; Hitoshi Ohto
Journal:  Blood Transfus       Date:  2016-11-07       Impact factor: 3.443

2.  Supernatant protein biomarkers of red blood cell storage hemolysis as determined through an absolute quantification proteomics technology.

Authors:  Angelo D'Alessandro; Monika Dzieciatkowska; Ryan C Hill; Kirk C Hansen
Journal:  Transfusion       Date:  2016-01-26       Impact factor: 3.157

Review 3.  Quality Assessment of Established and Emerging Blood Components for Transfusion.

Authors:  Jason P Acker; Denese C Marks; William P Sheffield
Journal:  J Blood Transfus       Date:  2016-12-14

4.  Effects of leukoreduction on storage lesions in whole blood and blood components of dogs.

Authors:  Annalisa Stefani; Katia Capello; Antonio Carminato; Wendy Wurzburger; Tommaso Furlanello; Valentina Bertazzo; Elisabetta Marsilio; Elena Albertin; Giacomo La Pietra; Elisa Bozzato; Franco Mutinelli; Marta Vascellari
Journal:  J Vet Intern Med       Date:  2021-02-16       Impact factor: 3.333

5.  Effect of Irradiation on Microparticles in Red Blood Cell Concentrates.

Authors:  Chi Hyun Cho; Seung Gyu Yun; Young Eun Koh; Chae Seung Lim
Journal:  Ann Lab Med       Date:  2016-07       Impact factor: 3.464

6.  Redox Status, Procoagulant Activity, and Metabolome of Fresh Frozen Plasma in Glucose 6-Phosphate Dehydrogenase Deficiency.

Authors:  Vassilis L Tzounakas; Federica Gevi; Hara T Georgatzakou; Lello Zolla; Issidora S Papassideri; Anastasios G Kriebardis; Sara Rinalducci; Marianna H Antonelou
Journal:  Front Med (Lausanne)       Date:  2018-02-05

Review 7.  The Role of Plasma Transfusion in Massive Bleeding: Protecting the Endothelial Glycocalyx?

Authors:  Stefano Barelli; Lorenzo Alberio
Journal:  Front Med (Lausanne)       Date:  2018-04-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.